- Latest available (Revised)
- Point in Time (01/07/2018)
- Original (As made)
Point in time view as at 01/07/2018.
There are currently no known outstanding effects for the The Health Service Products (Provision and Disclosure of Information) Regulations 2018, Section 17.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
17.—(1) A UK producer who is a medicines wholesaler must—
(a)record the information mentioned in paragraph (3) for each purchase by the producer of a relevant presentation of health service medicines for supply (including any purchase which requires the presentation to be imported into the United Kingdom), and
(b)keep that information for a period of four years beginning with the day on which it is recorded.
(2) The information is—
(a)the name of the person from whom the presentation is purchased,
(b)the quantity, by pack size, purchased,
(c)the net purchase amount, or a reasonable estimate of the net purchase amount, for the purchase,
(d)the terms on which the discounts, payments, or payments or benefits in kind taken into account when calculating that amount were given,
(e)the name of the person to whom the discounts, payments, payments or benefits in kind were given, if that person is not the wholesaler, and
(f)if it is a presentation of made special health service medicine, the excipient formulations purchased (if any).
(3) A UK producer who is a medicines wholesaler must also—
(a)record the information mentioned in paragraph (4) for each supply by the wholesaler of a relevant presentation of health service medicine, and
(b)keep that information for a period of four years beginning with the day on which it is recorded.
(4) The information is—
(a)the name of the person to whom the presentation is supplied (“the purchaser”),
(b)if known to the producer, whether the purchaser is in Category A, B, C or D,
(c)the quantity, by pack size, supplied,
(d)the net sales income, or a reasonable estimate of the net sales income, for the supply to the purchaser,
(e)the terms on which any discounts, payments, or payments or benefits in kind taken into account when calculating that income were given by the producer,
(f)the name of the person to whom any of those any discounts, payments, or payments or benefits in kind were given, if that person is not the purchaser,
(g)if it is a presentation of made special health service medicine, the excipient formulations supplied (if any), and
(h)if known to the producer, whether the presentation is an English health service product, a Welsh health service product, a Scottish health service product or a Northern Ireland health service product.
(5) In this regulation, “relevant presentation of health service medicine”, in relation to a producer, means a presentation of health service medicine other than—
(a)a presentation which the producer has manufactured, or
(b)a presentation of imported special health service medicine.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: